DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that ...
SEATTLE & SAN DIEGO--(BUSINESS WIRE)--Phase Genomics, Inc., a leading developer of cutting-edge genomic solutions, and Element Biosciences, the developer of an innovative DNA sequencing platform ...
As Genomics England’s data management partner, ICON will use its powerful data management capabilities, and understanding of the growing role genomics data will have in clinical trials, to validate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback